Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 74

1.

Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression.

Aherne ST, Madden SF, Hughes DJ, Pardini B, Naccarati A, Levy M, Vodicka P, Neary P, Dowling P, Clynes M.

BMC Cancer. 2015 Apr 30;15:329. doi: 10.1186/s12885-015-1327-5.

2.

Inherited variability in a master regulator polymorphism (rs4846126) associates with survival in 5-FU treated colorectal cancer patients.

Pardini B, Bermejo JL, Naccarati A, Di Gaetano C, Rosa F, Legrand C, Novotny J, Vodicka P, Kumar R.

Mutat Res. 2014 Aug-Sep;766-767:7-13. doi: 10.1016/j.mrfmmm.2014.05.007. Epub 2014 Jun 7.

PMID:
25847265
3.

Elevated levels of 14-3-3 proteins, serotonin, gamma enolase and pyruvate kinase identified in clinical samples from patients diagnosed with colorectal cancer.

Dowling P, Hughes DJ, Larkin AM, Meiller J, Henry M, Meleady P, Lynch V, Pardini B, Naccarati A, Levy M, Vodicka P, Neary P, Clynes M.

Clin Chim Acta. 2015 Feb 20;441:133-41. doi: 10.1016/j.cca.2014.12.005. Epub 2014 Dec 23.

PMID:
25540887
4.

Polymorphisms in microRNA genes as predictors of clinical outcomes in colorectal cancer patients.

Pardini B, Rosa F, Naccarati A, Vymetalkova V, Ye Y, Wu X, di Gaetano C, Buchler T, Novotny J, Matullo G, Vodicka P.

Carcinogenesis. 2015 Jan;36(1):82-6. doi: 10.1093/carcin/bgu224. Epub 2014 Nov 3.

PMID:
25368035
5.

Single nucleotide polymorphisms within interferon signaling pathway genes are associated with colorectal cancer susceptibility and survival.

Lu S, Pardini B, Cheng B, Naccarati A, Huhn S, Vymetalkova V, Vodickova L, Buchler T, Hemminki K, Vodicka P, Försti A.

PLoS One. 2014 Oct 28;9(10):e111061. doi: 10.1371/journal.pone.0111061. eCollection 2014.

6.

Shorter leukocyte telomere length is independently associated with poor survival in patients with bladder cancer.

Russo A, Modica F, Guarrera S, Fiorito G, Pardini B, Viberti C, Allione A, Critelli R, Bosio A, Casetta G, Cucchiarale G, Destefanis P, Gontero P, Rolle L, Zitella A, Fontana D, Frea B, Vineis P, Sacerdote C, Matullo G.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2439-46. doi: 10.1158/1055-9965.EPI-14-0228. Epub 2014 Sep 18.

PMID:
25234236
7.

MicroRNA expression in relation to different dietary habits: a comparison in stool and plasma samples.

Tarallo S, Pardini B, Mancuso G, Rosa F, Di Gaetano C, Rosina F, Vineis P, Naccarati A.

Mutagenesis. 2014 Sep;29(5):385-91. doi: 10.1093/mutage/geu028.

PMID:
25150024
8.

Variations in mismatch repair genes and colorectal cancer risk and clinical outcome.

Vymetalkova V, Pardini B, Rosa F, Di Gaetano C, Novotny J, Levy M, Buchler T, Slyskova J, Vodickova L, Naccarati A, Vodicka P.

Mutagenesis. 2014 Jul;29(4):259-65. doi: 10.1093/mutage/geu014. Epub 2014 Apr 22.

9.

Colorectal cancer risk and patients' survival: influence of polymorphisms in genes somatically mutated in colorectal tumors.

Huhn S, Bevier M, Pardini B, Naccarati A, Vodickova L, Novotny J, Vodicka P, Hemminki K, Försti A.

Cancer Causes Control. 2014 Jun;25(6):759-69. doi: 10.1007/s10552-014-0379-1. Epub 2014 Apr 5.

PMID:
24706189
10.

Sardinians genetic background explained by runs of homozygosity and genomic regions under positive selection.

Di Gaetano C, Fiorito G, Ortu MF, Rosa F, Guarrera S, Pardini B, Cusi D, Frau F, Barlassina C, Troffa C, Argiolas G, Zaninello R, Fresu G, Glorioso N, Piazza A, Matullo G.

PLoS One. 2014 Mar 20;9(3):e91237. doi: 10.1371/journal.pone.0091237. eCollection 2014.

11.

Post-treatment recovery of suboptimal DNA repair capacity and gene expression levels in colorectal cancer patients.

Slyskova J, Cordero F, Pardini B, Korenkova V, Vymetalkova V, Bielik L, Vodickova L, Pitule P, Liska V, Matejka VM, Levy M, Buchler T, Kubista M, Naccarati A, Vodicka P.

Mol Carcinog. 2014 Mar 3. doi: 10.1002/mc.22141. [Epub ahead of print]

PMID:
24585457
12.

Molecular characteristics of mismatch repair genes in sporadic colorectal tumors in Czech patients.

Vymetalkova VP, Slyskova J, Korenkova V, Bielik L, Langerova L, Prochazka P, Rejhova A, Schwarzova L, Pardini B, Naccarati A, Vodicka P.

BMC Med Genet. 2014 Jan 31;15:17. doi: 10.1186/1471-2350-15-17.

13.

Association between CASP8 -652 6N del polymorphism (rs3834129) and colorectal cancer risk: results from a multi-centric study.

Pardini B, Verderio P, Pizzamiglio S, Nici C, Maiorana MV, Naccarati A, Vodickova L, Vymetalkova V, Veneroni S, Daidone MG, Ravagnani F, Bianchi T, Bujanda L, Carracedo A, Castells A, Ruiz-Ponte C, Morreau H, Howarth K, Jones A, Castellví-Bel S, Li L, Tomlinson I, Van Wezel T, Vodicka P, Radice P, Peterlongo P; EPICOLON Consortium.

PLoS One. 2014 Jan 21;9(1):e85538. doi: 10.1371/journal.pone.0085538. eCollection 2014. Erratum in: PLoS One. 2014;9(3):e91310.

14.

Meta-analysis of mismatch repair polymorphisms within the cogent consortium for colorectal cancer susceptibility.

Picelli S, Lorenzo Bermejo J, Chang-Claude J, Hoffmeister M, Fernández-Rozadilla C, Carracedo A, Castells A, Castellví-Bel S; Memebers of EPICOLON Consortium-Gastrointestinal Oncology Group of the Spanish Gastroenterological Association, Naccarati A, Pardini B, Vodickova L, Müller H, Talseth-Palmer BA, Stibbard G, Peterlongo P, Nici C, Veneroni S, Li L, Casey G, Tenesa A, Farrington SM, Tomlinson I, Moreno V, van Wezel T, Wijnen J, Dunlop M, Radice P, Scott RJ, Vodicka P, Ruiz-Ponte C, Brenner H, Buch S, Völzke H, Hampe J, Schafmayer C, Lindblom A.

PLoS One. 2013 Sep 6;8(9):e72091. doi: 10.1371/journal.pone.0072091. eCollection 2013.

15.

Variation within 3'-UTRs of base excision repair genes and response to therapy in colorectal cancer patients: A potential modulation of microRNAs binding.

Pardini B, Rosa F, Barone E, Di Gaetano C, Slyskova J, Novotny J, Levy M, Garritano S, Vodickova L, Buchler T, Gemignani F, Landi S, Vodicka P, Naccarati A.

Clin Cancer Res. 2013 Nov 1;19(21):6044-56. doi: 10.1158/1078-0432.CCR-13-0314. Epub 2013 Sep 13.

16.

Effect of blood storage conditions on DNA repair capacity measurements in peripheral blood mononuclear cells.

Allione A, Porcedda P, Russo A, Ricceri F, Simonelli V, Minoprio A, Guarrera S, Pardini B, Mazzei F, Dogliotti E, Giachino C, Matullo G.

Mutat Res. 2013 Sep;749(1-2):73-9. doi: 10.1016/j.mrfmmm.2013.05.001. Epub 2013 May 30.

PMID:
23727398
17.

Genetic variants in C-type lectin genes are associated with colorectal cancer susceptibility and clinical outcome.

Lu S, Bevier M, Huhn S, Sainz J, Lascorz J, Pardini B, Naccarati A, Vodickova L, Novotny J, Hemminki K, Vodicka P, Försti A.

Int J Cancer. 2013 Nov 15;133(10):2325-33. doi: 10.1002/ijc.28251. Epub 2013 May 29.

PMID:
23650115
18.

Polymorphisms in the XRCC1 gene modify survival of bladder cancer patients treated with chemotherapy.

Sacerdote C, Guarrera S, Ricceri F, Pardini B, Polidoro S, Allione A, Critelli R, Russo A, Andrew AS, Ye Y, Wu X, Kiemeney LA, Bosio A, Casetta G, Cucchiarale G, Destefanis P, Gontero P, Rolle L, Zitella A, Fontana D, Vineis P, Matullo G.

Int J Cancer. 2013 Oct 15;133(8):2004-9. doi: 10.1002/ijc.28186. Epub 2013 Apr 25.

19.

Shared ancestral susceptibility to colorectal cancer and other nutrition related diseases.

Huhn S, Bevier M, Rudolph A, Pardini B, Naccarati A, Hein R, Hoffmeister M, Vodickova L, Novotny J, Brenner H, Chang-Claude J, Hemminki K, Vodicka P, Försti A.

BMC Med Genet. 2012 Oct 5;13:94. doi: 10.1186/1471-2350-13-94.

20.

Differences in nucleotide excision repair capacity between newly diagnosed colorectal cancer patients and healthy controls.

Slyskova J, Naccarati A, Pardini B, Polakova V, Vodickova L, Smerhovsky Z, Levy M, Lipska L, Liska V, Vodicka P.

Mutagenesis. 2012 Jul;27(4):519-22. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk